Actinium Pharmaceuticals, Inc. (ATNM) Financials

ATNM Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 88.9 million 45.4 million
2023-06-30 99.1 million 46.0 million
2023-03-31 102.0 million 44.8 million
2022-12-31 114.2 million 47.7 million

ATNM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -11.2 million 921000
2023-06-30 -13.7 million 1.0 million
2023-03-31 -15.2 million 993000
2022-12-31 -7.8 million 979000

ATNM Net Income

No data available :(

ATNM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 83.0 million - 2.2 million
2023-06-30 91.3 million - 2.3 million
2023-03-31 94.5 million - 2.5 million
2022-12-31 108.9 million - 2.6 million

ATNM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 27.1 million
2023-06-30 26.2 million
2023-03-31 25.7 million
2022-12-31 20.6 million

ATNM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 30000 11.6 million 2.7 million -
2023-06-30 47000 11.1 million 4.6 million -
2023-03-31 76000 7.8 million 3.7 million -
2022-12-31 16000 7.3 million 4.0 million -

ATNM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 200000
2023-06-30 - 209000
2023-03-31 - 182000
2022-12-31 114000 161000

ATNM

Price: $8.96

52 week price:
4.00
9.86

Earnings Per Share: -1.93 USD

P/E Ratio: -2.83

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 219900

Market Capitalization: 246.7 million

Links: